Surface plasmon resonance for real-time monitoring of molecular interactions between a triple helix forming oligonucleotide and the Sp1 binding sites of human Ha-ras promoter: Effects of the DNA-binding drug chromomycin

International Journal of Oncology

Volumn 12, Issue 2, 1998, Pages 337-343

  Rutigliano, C ^a   Bianchi, N ^a   Tomassetti, M ^a   Pippo, L ^a   Mischiati, C ^a   Feriotto, G ^a   Gambari, R ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

DNA binding drugs; Ha ras; surface plasmon resonance; TFO

Indexed keywords

CHROMOMYCIN; OLIGONUCLEOTIDE; TRANSCRIPTION FACTOR SP1;

ARTICLE; BINDING AFFINITY; BINDING SITE; BIOSENSOR; DNA SEQUENCE; DRUG DNA BINDING; GENETIC TRANSCRIPTION; HUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; PROMOTER REGION; TRIPLE HELIX;

BINDING SITES; CARCINOGENS; CHROMOMYCINS; DNA-BINDING PROTEINS; GENES, RAS; HUMANS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES; PROMOTER REGIONS (GENETICS); SP1 TRANSCRIPTION FACTOR; SURFACE PLASMON RESONANCE; TIME FACTORS;

EID: 0031932110     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.2.337     Document Type: Article

References (30)

1. Dervan PB: Design of sequence-specific DNA binding molecules. Science 232: 464-471, 1986.
2. Broggini M, Ponti M, Ottolenghi S, D'Incalci M, Mongelli N and Mantovani R: Distamycins inhibit the binding of OTF-1 and NFE-1 transfactors to their conserved DNA elements. Nucleic Acids Res 7: 1051-1061, 1989.
3. Welch JJ, Rausher FJ III and Beerman TA: Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters. J Biol Chem 269: 31051-31058, 1994.
4. Dorn A, Affolter M, Muller M, Gehring WJ and Leupin W: Distamycin-induced inhibition of homeodomain-DNA complexes. EMBO J11: 279-286, 1992.
5. Feriotto G, Mischiati C and Gambari R: Sequence-specific recognition of the HIV-1 long terminal repeat by distamycin: a DNase I footprinting study. Biochem J 299: 451-458, 1994.
6. Feriotto G, Ciucci A, Mischiati C, Animati F, Lombardi P, Giacomini P, Arcamone F and Gambari R: Binding of Epstein-Barr virus nuclear antigen 1 to DNA: inhibition by distamycin and two novel distamycin analogues. Eur J Pharmacol 267: 143-149, 1994.
7. Gambari R, Barbieri R, Nastruzzi C, Chiorboli V, Feriotto G, Natali PG, Giacomini P and Arcamone F: Distamycin inhibits the binding of a nuclear factor to the -278/-256 upstream sequence of the human HLA-DRα gene. Biochem Pharmacol 41: 495-502, 1991.
8. Bianchi N, Passadore M, Rutigliano C, Feriotto G, Mischiati C and Gambari R: Targeting of the Sp1 binding sites of HIV-1 long terminal repeat with chromomycin. Biochem Pharmacol 52: 1489-1498, 1996.
9. Gambari R and Nastruzzi C: DNA-binding activity and biological effects of aromatic polyamidines. Biochem Pharmacol 47: 599-610, 1994.
10. Feriotto G, Mischiati C, Bianchi N, Passadore M and Gambari R: Binding of distamycin and chromomycin to human immunodeficiency type 1 virus DNA: a non-radioactive automated footprinting study. Eur J Pharmacol 290: 85-93, 1995.
11. Bianchi N, Passadore M, Feriotto G, Mischiati C, Gambari R and Piva R: Alteration of the expression of human estrogen receptor gene by distamycin. J Steroid Biochem Mol Biol 54: 211-215, 1995.
12. Passadore M, Bianchi N, Feriotto G, Mischiati C, Giacomini P, Piva R and Gambari R: Differential effects of distamycin analogues on amplification of human gene sequences by polymerase-chain reaction. Biochem J 308: 513-519, 1995.
13. Ray R, Snyder RC, Thomas S, Koller CA and Miller DM: Mithramycin blocks protein binding and function of the SV40 early promoter. J Clin Invest 83: 2003-2007, 1989.
14. Snyder RC, Ray R, Blume S and Miller D: Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters.. Biochemistry 30: 4290-4297, 1991.
15. Faisst S and Meyer S: Compilation of vertebrate-encoded transcription factors. Nucleic Acids Res 20: 3-26, 1992.
16. McShean WM, Rossen RD, Laughter AH, Trial J, Kessler DJ, Zendegui JG, Hogan ME and Orson FM: Inhibition of transcription of HIV-1 in infected human cells by oligodeoxynucleotides designed to form DNA triple helices. J Biol Chem 267:5712-5721, 1992.
17. Mayfield C, Ebbinghaus S, Gee J, Jones D, Rodu B, Squibb M and Miller D: Triplex formation by the human Ha-ras promoter inhibits Sp1 binding and in vitro transcription. J Biol Chem 269: 18232-18238, 1994.
18. Scanlon KJ, Ohta Y, Ishida H, Kijima H, Ohkawa T, Kaminski A, Tsai J, Horng G and Kashani MK: Oligonucleotide-mediated modulation of mammalian gene expression FASEB J 9: 1288-1296, 1995.
19. Maher LJ III, Wold B and Dervan PB: Inhibition of DNA binding proteins by oligonucleotide-directed triple helix formation. Science 245: 725-730, 1989.
20. Cooney M, Czernuszewiez G, Postel EH, Flint SJ and Hogan ME: Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro. Science 241: 456-459 1988
21. Orson FM, Thomas DW, McShean WM, Kessler DJ and Hogan ME: Oligonucleotide inhibition of IL2R alpha mRNA transcription by promoter region collinear triplex formation in lymphocytes. Nucleic Acids Res 19: 3435-3441, 1991
22. Ebbinghaus SW, Gee JE, Rodu B, Mayfield CA and Miller DM: Triplex formation inhibits HER-2/neu transcription in vitro J Clin Invest 92: 2433-2439, 1993.
23. Malmqvist M: Biospecific interactions analysis using biosensor technology. Nature 361: 186-187, 1993.
24. Jonsson U, Fagerstam L, Ivarsson B, Johnsson B and Karlsson R: Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. Bio Techniques 11: 620-627, 1991.
25. Nilsson P, Pcrsson B, Uhlén M and Nygren P-A: Real-time monitoring of DNA manipulations using biosensor technology. Anal Biochem 224: 400-408, 1995.
26. Ito T, Smith CL and Cantor CR: Sequence-specific DNA purification by triplex affinity capture. Proc Natl Acad Sci USA 89: 495-498, 1992.
27. Van Dyke WW and Dervan PB: Chromomycin, mithramycin and olivomycin binding sites on heterogeneous deoxyribonucleic acid. Footprinting with (methidiumpropyl-EDTA) iron(II). Biochemistry 22: 2373-2377, 1983.
28. Gambari R, Bianchi N, Rutigliano C, Borsetti E, Tomassetti M, Feriotto G and Zorzato F: Surface plasmon resonance for real time detection of molecular interactions between chromomycin and target DNA sequences. Int J Oncol 11: 145-149, 1997.
29. Kadonaga JT, Carner KR, Masiarz FR and Tjian R: Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell 51: 1079-1090, 1987.
30. Kiaris H and Spandidos DA: Mutations of ras genes in human tumors. Int J Oncol 7: 413-421, 1995.